Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis

BACKGROUND: Although antifibrotic drugs, including nintedanib and pirfenidone, slow the progression of idiopathic pulmonary fibrosis (IPF), there is little data about the timing of start of antifibrotic treatment in real-world clinical practice. The present study aimed to clarify the efficacy of nin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugino, Keishi, Ono, Hirotaka, Watanabe, Natsumi, Ando, Masahiro, Tsuboi, Eiyasu, Homma, Sakae, Kishi, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272304/
https://www.ncbi.nlm.nih.gov/pubmed/34246227
http://dx.doi.org/10.1186/s12890-021-01595-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272304/
https://www.ncbi.nlm.nih.gov/pubmed/34246227
http://dx.doi.org/10.1186/s12890-021-01595-3

Ejemplares similares